P

Inventor

BELL JOHN C

14 patents
⚠️ This page may combine multiple inventors who share the name “BELL JOHN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BELL JOHN C

4 patents
US9045729B2Jun 2, 2015

Oncolytic rhabdovirus

BELL JOHN C8 citations81
US10603351B2Mar 31, 2020

Engineered synergistic oncolytic viral symbiosis

BELL JOHN C2 citations69
US8147822B1Apr 3, 2012

Oncolytic virus

BELL JOHN C2 citations54
US8282917B2Oct 9, 2012

Mutant viruses and uses thereof

BELL JOHN C1 citations43

OTTAWA HOSPITAL RES INST

3 patents
US7731974B2Jun 8, 2010

Mutant vesicular stomatitis viruses and uses thereof

OTTAWA HOSPITAL RES INST66 citations95
US9896664B2Feb 20, 2018

Oncolytic rhabdovirus

OTTAWA HOSPITAL RES INST0 citations51
US11802292B2Oct 31, 2023

Modified orthopoxvirus vectors

OTTAWA HOSPITAL RES INST0 citations47

UNIV OTTAWA

1 patent
US7192580B2Mar 20, 2007

Purging of cells using viruses

UNIV OTTAWA24 citations90

BECS TECHNOLOGY INC

1 patent
US6137282AOct 24, 2000

Time-domain reflectometry user input device

BECS TECHNOLOGY INC33 citations88

TRANSFER TECHNOLOGIES INC

1 patent
US4766547AAug 23, 1988

Computer controlled conveyor system

TRANSFER TECHNOLOGIES INC80 citations86

ROBARTS RES INST

1 patent
US7582614B2Sep 1, 2009

Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection

ROBARTS RES INST12 citations81

BECS TECHNOLOGY

1 patent
US6940421B2Sep 6, 2005

Method and apparatus for efficient use of communication channels for remote telemetry

BECS TECHNOLOGY17 citations80

EKSTROEM IND INC

1 patent
US4311354AJan 19, 1982

Meter disconnect adaptor

EKSTROEM IND INC9 citations73

MCFADDEN GRANT

1 patent
US8227440B2Jul 24, 2012

Use of Myxoma virus for the therapeutic treatment of cancer and chronic viral infection

MCFADDEN GRANT3 citations60